<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a case of a 38-year old male with inv(16)(p13q22) positive <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) with <z:hpo ids='HP_0001880'>eosinophilia</z:hpo>, relapsing after a molecular remission of almost three years </plain></SENT>
<SENT sid="1" pm="."><plain>Remarkably, the <z:mpath ids='MPATH_336'>leukaemia</z:mpath> at relapse was identified as a precursor-B-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) by cytology and immunophenotyping, but was inv(16)(p13q22) positive as revealed by interphase FISH, FICTION analysis, and real-time quantitative PCR </plain></SENT>
<SENT sid="2" pm="."><plain>Analysis of immunoglobulin and T-cell receptor genes showed a bi-allelic DH2-JH rearrangement at relapse, but not at diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>These findings indicate a myeloid to lymphoid lineage switch from an inv(16)(p13q22) positive <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and show that IGH gene rearrangements can occur in the presence of CBFB-MYH11 fusion transcripts </plain></SENT>
</text></document>